{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:51:24Z","timestamp":1767149484741,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/j.tjog.2022.02.009","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000}}],"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.tjog.2022.02.009","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T16:32:50Z","timestamp":1648485170000},"page":"230-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["RETRACTED: Maternal blood concentration of tadalafil in pregnancy: Comparison of pregnant and non-pregnant women"],"prefix":"10.1016","volume":"61","author":[{"given":"Naosuke","family":"Enomoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Maki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Takakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayo","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Katsuragi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjog.2022.02.009_bib1","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.AOG.0000429658.85846.f9","article-title":"ACOG Practice bulletin no. 134: fetal growth restriction","volume":"121","author":"American College of Obstetricians and Gynecologists","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tjog.2022.02.009_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bpobgyn.2007.06.004","article-title":"Diagnosis and management of fetal growth restriction: the role of fetal therapy","volume":"22","author":"Hui","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.tjog.2022.02.009_bib3","first-page":"1","article-title":"Cardiac function and tadalafil used for treating fetal growth restriction in pregnant women without cardiovascular disease","volume":"20","author":"Tanaka","year":"2018","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.tjog.2022.02.009_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ajh\/hpx130","article-title":"Tadalafil improves L-NG-nitroarginine methyl ester-induced preeclampsia with fetal growth restriction-like symptoms in pregnant mice","volume":"31","author":"Yoshikawa","year":"2017","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.tjog.2022.02.009_bib5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/jog.13345","article-title":"Safety and dose-finding trial of tadalafil administered for fetal growth restriction: a phase-1 clinical study","volume":"43","author":"Kubo","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.tjog.2022.02.009_bib6","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/jog.13335","article-title":"Treatment using tadalafil for severe pre-eclampsia with fetal growth restriction","volume":"43","author":"Tanaka","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.tjog.2022.02.009_bib7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/jog.13218","article-title":"Retrospective study of tadalafil for fetal growth restriction: impact on maternal and perinatal outcomes","volume":"43","author":"Kubo","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.tjog.2022.02.009_bib8","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1742-1241.2006.01049.x","article-title":"Comparison of phosphodiesterase type 5 (PDE5) inhibitors","volume":"60","author":"Wright","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.tjog.2022.02.009_bib9","doi-asserted-by":"crossref","first-page":"e020948","DOI":"10.1136\/bmjopen-2017-020948","article-title":"TADAFER study group. TADAFER II: tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial","volume":"8","author":"Umekawa","year":"2018","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.tjog.2022.02.009_bib10","first-page":"256","article-title":"Safety evaluation of tadalafil treatment for fetuses with early-onset growth restriction (TADAFER): results from the phase II trial","volume":"8","author":"Maki","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.tjog.2022.02.009_bib11","first-page":"78","article-title":"Improved prediction of pre-eclampsia by two-stage screening of uterine arteries using the early diastolic notch and color Doppler imaging","volume":"82","author":"Bower","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tjog.2022.02.009_bib12","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1067\/mob.2001.117187","article-title":"A\u00a0longitudinal study of quantitative uterine blood flow with the use of color power angiography in appropriate for gestational age pregnancies","volume":"185","author":"Konje","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2022.02.009_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-60327-325-1_15","article-title":"Reverse-phase high-performance liquid chromatography (HPLC) analysis of retinol and retinyl esters in mouse serum and tissues","volume":"652","author":"Kim","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.tjog.2022.02.009_bib14","unstructured":"Nippon Shinyaku CO., LTD.: Zalutia\u00ae , interview form."}],"updated-by":[{"DOI":"10.1016\/j.tjog.2023.10.001","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T00:00:00Z","timestamp":1700870400000},"record-id":"49719"},{"DOI":"10.1016\/j.tjog.2022.02.009","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000}},{"DOI":"10.1016\/j.tjog.2023.10.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000}}],"container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455922000092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455922000092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:20:43Z","timestamp":1760898043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1028455922000092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1028455922000092"],"URL":"https:\/\/doi.org\/10.1016\/j.tjog.2022.02.009","relation":{},"ISSN":["1028-4559"],"issn-type":[{"value":"1028-4559","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Maternal blood concentration of tadalafil in pregnancy: Comparison of pregnant and non-pregnant women","name":"articletitle","label":"Article Title"},{"value":"Taiwanese Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjog.2022.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}